First People's Hospital Of Hangzhou
Clinical trials sponsored by First People's Hospital Of Hangzhou, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New drug combo aims to simplify stomach infection treatment Results expected Oct 2026 (estimated)
- Scientists dive deep into rare lung Cancer's DNA and immune defenses Results expected Aug 2027 (estimated)
-
New hope for elderly AML patients: drug combo aims to control disease without harsh chemo
Disease control Not yet recruitingThis study tests a combination of three drugs (venetoclax, homoharringtonine, and azacitidine) plus a growth factor (G-CSF) in 61 older or frail adults with newly diagnosed acute myeloid leukemia (AML) who cannot tolerate standard intensive chemotherapy. The goal is to see if thi…
Phase 2 • Sponsor: First People's Hospital of Hangzhou • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
New drug combo aims to simplify stomach infection treatment
Disease control Not yet recruitingThis study tests two ways of taking amoxicillin with tegoprazan to treat H. pylori, a stomach infection that can cause ulcers. About 240 adults will take the same total daily dose of antibiotics, but one group takes it three times a day and the other twice a day. The goal is to s…
Phase 4 • Sponsor: First People's Hospital of Hangzhou • Aim: Disease control
Last updated Jun 27, 2026 07:58 UTC
-
New surgical bag may speed up fibroid removal
Symptom relief Not yet recruitingThis trial tests a new single-channel bag used during keyhole surgery to remove uterine fibroids. The bag holds the fibroid while it is cut into smaller pieces, and the goal is to see if it makes the surgery faster and simpler than the current two-channel bag. About 78 women aged…
Sponsor: First People's Hospital of Hangzhou • Aim: Symptom relief
Last updated Jun 27, 2026 12:04 UTC
-
Can acupuncture help you quit antidepressants?
Symptom relief Not yet recruitingThis study tests whether intradermal acupuncture (tiny needles left under the skin for days) can help people with depression safely reduce or stop their SSRI medication. 114 adults planning to taper off SSRIs will be split into three groups: tapering alone, tapering with sham acu…
Sponsor: First People's Hospital of Hangzhou • Aim: Symptom relief
Last updated Jun 27, 2026 12:00 UTC
-
Can a 1,500-Patient biobank unlock the secrets of chronic pancreatitis?
Knowledge-focused Not yet recruitingThis observational study will follow 1,500 adults with chronic pancreatitis for several years, collecting health data and biological samples like blood, stool, and bile. The goal is to track how the disease changes over time, especially in those undergoing ERCP treatment, and to …
Sponsor: First People's Hospital of Hangzhou • Aim: Knowledge-focused
Last updated Aug 20, 2026 00:00 UTC